{"categories":[],"blog_title":"Research Industry","title":"Osteogenesis Imperfecta Disease Treatment Market Analysis and Research Report: Ken Research","author_name":"Kenresearch","height":"190","provider_name":"Hatena Blog","published":"2018-10-18 16:05:56","image_url":"https://cdn-ak.f.st-hatena.com/images/fotolife/K/Kenresearch/20181018/20181018160551.jpg","width":"100%","blog_url":"https://kenresearch.hatenadiary.jp/","url":"https://kenresearch.hatenadiary.jp/entry/2018/10/18/160556","author_url":"https://blog.hatena.ne.jp/Kenresearch/","version":"1.0","type":"rich","provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fkenresearch.hatenadiary.jp%2Fentry%2F2018%2F10%2F18%2F160556\" title=\"Osteogenesis Imperfecta Disease Treatment Market Analysis and Research Report: Ken Research - Research Industry\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","description":"According to study, \u201cOsteogenesis Imperfecta - Pipeline Review, H2 2018\u201d some of the major companies that are working in the osteogenesis imperfecta are Amgen Inc, Bone Therapeutics SA, Genzyme Corp, Mario Biopharma Group Plc, Mesentech Inc, SOM Biotech SL. OI is classified into many types based on \u2026"}